28 results
424B5
MREO
Mereo Biopharma Group Plc
23 Oct 20
Prospectus supplement for primary offering
4:40pm
result in less favorable results to the plaintiff(s) in any such action.
The deposit agreement governing our ADSs provides that holders and beneficial … would have had, including results that could be less favorable to the plaintiff(s) in any such action, depending on, among other things, the nature
S-3
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
if the corporation fails to enforce the right itself. The complaint must:
∎ state that the plaintiff was a stockholder at the time of the transaction of which … the plaintiff complains or that the plaintiffs shares thereafter devolved on the plaintiff by operation of law; and
∎ allege with particularity
F-3
MREO
Mereo Biopharma Group Plc
6 Oct 20
Shelf registration (foreign)
4:25pm
. The complaint must:
∎ state that the plaintiff was a stockholder at the time of the transaction of which the plaintiff complains or that the plaintiffs shares … thereafter devolved on the plaintiff by operation of law; and
∎ allege with particularity the efforts made by the plaintiff to obtain the action
424B5
MREO
Mereo Biopharma Group Plc
9 Feb 21
Prospectus supplement for primary offering
5:24pm
under the deposit agreement, which could result in less favorable results to the plaintiff(s) in any such action.
The deposit agreement governing our … result in different results than a trial by jury would have had, including results that could be less favorable to the plaintiff(s) in any such action
424B5
MREO
Mereo Biopharma Group Plc
10 Feb 21
Prospectus supplement for primary offering
4:53pm
results to the plaintiff(s) in any such action.
The deposit agreement governing our ADSs provides that holders and beneficial owners of ADSs irrevocably … , including results that could be less favorable to the plaintiff(s) in any such action, depending on, among other things, the nature of the claims, the judge
F-3/A
9894xa
27 Sep 21
Shelf registration (foreign) (amended)
4:18pm
F-3/A
ncvxjgjkwnen1uh32
7 Sep 21
Shelf registration (foreign) (amended)
4:06pm
F-3
h7ippkqqgiqba82rv
5 Aug 21
Shelf registration (foreign)
4:33pm
F-1
eo1je zraxtke0
18 Feb 20
Registration statement (foreign)
5:15pm
6-K
EX-10.2
p1nxbswmt6u
19 Feb 20
Mereo BioPharma Announces Equity Investment of $3 Million from New U.S. Institutional Investor
9:32am
6-K
EX-10.2
5zmamyb 5lu31bfw
10 Feb 20
Current report (foreign)
7:20am
10-K
EX-10.30
bq7w3wbzu5ewvq8ar2
27 Mar 24
Annual report
5:20pm
F-4/A
wm89fvfvu umqq
15 Mar 19
Registration of securities (foreign) (amended)
5:08pm
F-4
iawcgtov obb4cr85qgm
25 Jan 19
Registration of securities (foreign)
12:00am
424B3
fwspk52zhtu yjhc
20 Mar 19
Prospectus supplement
4:58pm
F-3
EX-1.2
2wjl50bi6x
5 Aug 21
Shelf registration (foreign)
4:33pm
S-3
EX-1.2
6awm1 ma42yapfwo
15 May 24
Shelf registration
4:49pm